mailed
on 06 Dec 2023
Last Applicant/ Owned by
4100-1155, boulevard René-Lévesque Ouest
Montréal (Québec)
CA
H3B3V2
Serial Number
97115991 filed on 09th Nov 2021
Registration Number
N/A
Correspondent Address
Benjamin M. Cantor
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific Read More
Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
No 97115991
No Service Mark
No SWA0583TUS
Yes
Yes
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 29th Jan 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 29th Jan 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 29th Jan 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Dec 2023 | ASSIGNED TO LIE |
| 06th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 06th Dec 2023 | SUSPENSION LETTER WRITTEN |
| 06th Dec 2023 | LETTER OF SUSPENSION E-MAILED |
| 06th Dec 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 06th Jul 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
